By American Society of Retina Specialists (ASRS)
Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS) offering the hi
... more
The podcast currently has 22 episodes available.
On this episode of ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum, Dr. Timothy Murray welcomes David S. Boyer, MD, of Retina Vitreous Associates Medical Group (LA Retina) Los Angeles, CA, to discuss real-world outcomes for use of the 0.19 mg fluocinolone implant in treating diabetic macular edema in 148 eyes, documenting stable VA, decreased central subfield thickness, and a reduced need for intravitreal anti-VEGF. Tune in for a discussion on why the 0.19 mg fluocinolone acetonide intravitreal implant provided long-term stabilization of VA and macular anatomy in patients with DME, despite a significant reduction in treatment frequency.
For more information, visit www.ASRS.org/JVRDForum.
Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS), offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief for JVRD as he discusses cutting-edge developments featured in JVRD with the lead authors who share clinical pearls and explore their significance for advancing patient care.
On this episode of ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum, Dr. Timothy Murray welcomes Michael J. Shapiro, MD, of Retina Consultants in Chicago, IL, who discusses the aggressive onset of familial exudative vitreoretinopathy (FEVR)–like vascular disease in a 3-year-old patient with mutations in LRP5 and TSPAN12 and a 16-year follow-up after laser ablation. Tune in for a discussion on mutational alterations associated with FEVR that suggest genetic testing is becoming the norm for atypical pediatric retinal diseases.
For more information, visit www.ASRS.org/JVRDForum.
Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS) offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief for JVRD as he discusses cutting-edge developments featured in JVRD with the lead authors who share clinical pearls and explore their significance for advancing patient care.
On this episode of the JVRD Author's Forum, Dr. Timothy Murray joins Philip J. Ferrone, MD, FASRS, to discuss a JVRD case report from the March/April 2024 issue updating our understanding of treatments and outcomes in 36 eyes of 18 patients with incontinentia pigmenti.
For more information visit www.ASRS.org/JVRDForum.
Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS) offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief for JVRD as he discusses cutting-edge developments featured in JVRD with the lead authors who share clinical pearls and explore their significance for advancing patient care.
Audio episodes are available on Amazon Music, Apple Podcasts, Google Podcasts, Spotify and other podcast directories.
On this episode of the JVRD Author's Forum, Dr. Timothy Murray joins John T. Thompson, MD, Associate Editor-in-Chief, to discuss a JVRD article from the March/April 2024 issue on the updated application of the 2020 spectral-domain optical coherence tomography (SD-OCT) consensus to the preoperative classification of macular hole and other macular pathologies to determine whether SD-OCT classification can be useful in determining visual outcomes.
For more information visit www.ASRS.org/JVRDForum.
Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS) offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief for JVRD as he discusses cutting-edge developments featured in JVRD with the lead authors who share clinical pearls and explore their significance for advancing patient care.
Audio episodes are available on Amazon Music, Apple Podcasts, Google Podcasts, Spotify and other podcast directories.
In this episode, Dr. Timothy Murray joins Dr. Jennifer Aye to talk about a case of recurrent aggressive ciliochoroidal melanoma requiring enucleation after brachytherapy elsewhere for recurrence at the biopsy site. The tumor showed progression from gene expression profiling (GEP) class 1A, PRAME negative to GEP Class 1b.
For more information visit www.ASRS.org/JVRDForum.
Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS) offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief for JVRD as he discusses cutting-edge developments featured in JVRD with the lead authors who share clinical pearls and explore their significance for advancing patient care.
Audio episodes are available on Amazon Music, Apple Podcasts, Google Podcasts, Spotify and other podcast directories.
In this episode, Dr. Timothy Murray joins Dr. Lejla Vajzovic to discuss the impact of e-cigarette use on macular perfusion employing optical coherence tomography angiography (OCTA) in a study of 25 patients. Learn if there are differences in retinal microvasculature measurements in patients using e-cigarettes compared to nonsmoker control groups.
For more information visit www.ASRS.org/JVRDForum.
Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS) offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief for JVRD as he discusses cutting-edge developments featured in JVRD with the lead authors who share clinical pearls and explore their significance for advancing patient care.
Audio episodes are available on Amazon Music, Apple Podcasts, Google Podcasts, Spotify, and other podcast directories.
In this episode, Dr. Timothy Murray welcomes Steven Yeh, MD, University of Nebraska Medical Center, Truhlsen Eye Institute to discuss 3 cases of retinopathy secondary to ritonavir use in the treatment of HIV. The review identified 3 patients with a history of HIV treated with antiretroviral therapy including ritonavir who had been evaluated for bilateral vision loss in both eyes. Explore why ritonavir toxicity should be considered in the differential diagnosis of retinopathy among patients with an exposure history.
For more information visit www.ASRS.org/JVRDForum.
Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS) offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief for JVRD as he discusses cutting-edge developments featured in JVRD with the lead authors who share clinical pearls and explore their significance for advancing patient care.
Audio episodes are available on Amazon Music, Apple Podcasts, Google Podcasts, Spotify, and other podcast directories.
On this episode, Dr. Murray welcomes Andre Witkin, MD, Associate Professor, Tufts University School of Medicine, Boston, MA, to discuss the article, Retinal Vasculitis After Intravitreal Pegcetacoplan: Report From the ASRS Research and Safety in Therapeutics (ReST) Committee.
On February 17, 2023, pegcetacoplan 15mg (Syfovre – Apellis Pharmaceuticals, Waltham MA) was approved by the US Food and Drug Administration (FDA) to treat geographic atrophy (GA) secondary to age-related macular degeneration (AMD). Beginning in April 2023, the American Society of Retina Specialists (ASRS) Research and Safety in Therapeutics (ReST) Committee began receiving reports of intraocular inflammation (IOI) following intravitreal pegcetacoplan administration. In addition to cases of IOI without retinal vascular involvement, several reported cases included retinal vasculitis resulting in occlusive retinal vasculopathy and significant vision loss. The American Society of Retina Specialists (ASRS) Research and Safety in Therapeutics (ReST) Committee, as well as an expert panel, performed a retrospective review of cases of retinal vasculitis reported to the ASRS. Clinical and imaging characteristics were reviewed for evidence of retinal vasculitis and analyzed.
For more information visit www.ASRS.org/JVRDForum.
Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS) offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief for JVRD as he discusses cutting-edge developments featured in JVRD with the lead authors who share clinical pearls and explore their significance for advancing patient care.
Audio episodes are available on Amazon Music, Apple Podcasts, Google Podcasts, Spotify and other podcast directories.
On this episode, Dr. Timothy Murray welcomes Dr. Baruch Kuppermann, Gavin Herbert Eye Institute, University of California, Irvine, California, to explore evidence from other specialties regarding cross-switching between biosimilars, and learn if there are any foreseen patient safety concerns for retina specialists.
For more information visit www.ASRS.org/JVRDForum.
Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS) offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief for JVRD as he discusses cutting-edge developments featured in JVRD with the lead authors who share clinical pearls and explore their significance for advancing patient care.
Audio episodes are available on Amazon Music, Apple Podcasts, Google Podcasts, Spotify and other podcast directories.
Explore the podcast
On this episode, Dr. Timothy Murray welcomes Aleksandra Rachitskaya, MD, FASRS, of Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio to explore the effect of syringe type on developing sustained intraocular pressure (IOP) increases. Learn how the type of syringe may or may not affect outcomes.
For more information visit www.ASRS.org/JVRDForum.
Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS) offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief for JVRD as he discusses cutting-edge developments featured in JVRD with the lead authors who share clinical pearls and explore their significance for advancing patient care. Audio episodes are available on Amazon Music, Apple Podcasts, Google Podcasts, Spotify and other podcast directories.
The podcast currently has 22 episodes available.
93 Listeners
1 Listeners